InspireMD, Inc.

Company Listings from SPi: InspireMD, Inc.

You are here: Home >> SPi Company Listings >> InspireMD, Inc.

 

InspireMD, Inc.

Website:
http://

Search for other references to "inspiremd" on SPi News

Latest InspireMD, Inc. News

InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the 25th January 2019, in Leipzig, Germany TEL AVIV, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovas...... 14:34 GMT Friday 18th January 2019

InspireMD Announces the Distribution of CGuard™ Embolic Prevention System in South Africa TEL AVIV, Israel, Jan. 14, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 13:00 GMT Monday 14th January 2019

InspireMD Receives Noncompliance Notice from NYSE American TEL AVIV, Israel, Jan. 11, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 21:30 GMT Friday 11th January 2019

InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 13:00 GMT Tuesday 18th December 2018

InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium) TEL AVIV, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 13:00 GMT Thursday 29th November 2018

InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 13:00 GMT Wednesday 28th November 2018

InspireMD Announces Upcoming Presentations at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium) TEL AVIV, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 13:00 GMT Tuesday 13th November 2018

InspireMD Announces Third Quarter 2018 Financial Results and Provides Corporate Update TEL AVIV, Israel, Nov. 06, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...... 12:00 GMT Tuesday 6th November 2018

InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6 TEL AVIV, Israel, Oct. 30, 2018 (GLOBE NEWSWIRE) --  InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stro...... 12:00 GMT Tuesday 30th October 2018

InspireMD Announces Presentation of Preliminary Cumulative Three-Year CGuard™ EPS Safety and Efficacy Data at the Transcatheter Cardiovascular Therapeutics 2018 Conference TEL AVIV, Israel, Sept. 27, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of strok...... 14:28 GMT Thursday 27th September 2018

Buy InspireMD, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us